2 FTSE 250 stocks I’ll be watching this week

Stephen Wright is watching for trading updates from Greggs and Persimmon this week. But which FTSE 250 stock is on his buy list?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Person holding magnifying glass over important document, reading the small print

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

A couple of FTSE 250 companies are set to release trading updates this week – both on the 10th. One is Greggs (LSE:GRG) and the other is Persimmon (LSE:PSN).

In both cases, I’m going to be watching closely. But my reasons for being interested in each are quite different.

Greggs

Greggs is on the list of stocks I’d like to buy. The stock currently trades at a price-to-earnings (P/E) ratio of just under 20, which is intrinsically fairly high but low compared to its historic levels.

The stock fell 7% when the business reported earnings in August as inflation cut into operating margins. Despite this, revenue and profits still showed what I thought was decent growth.

Since then, though, inflation in the UK has fallen significantly. So I’ll be interested to see how this is affecting the company’s profitability and how far this is an ongoing risk.

In addition, I’ll be looking to see how the firm is progressing towards its ambition of 3,000 outlets. To my mind, the potential growth from new stores is an important part of justifying its 20 P/E ratio.

I think customers associate Greggs with consistency, convenience, and low prices. As a result, I suspect it might hold up better than its competitors if the UK enters a recession in 2024.

I’m therefore looking to use the trading update for two things. The first is to assess the view of the company that I have and the second is to look for a potential buying opportunity.

Persimmon

By contrast, Persimmon isn’t really a stock I’m interested in buying. In the UK housebuilder space, I prefer Taylor Wimpey or Vistry, but I have an interest in the space for a number of other reasons.

I own shares in brick manufacturer Forterra, as well as real estate investment trusts Primary Health Properties and Supermarket Income REIT. Each of these is related to the property market.

With Forterra, the company makes more money when construction output is strong. And Primary Health Properties and Supermarket Income REIT both stand to benefit from higher property prices.

I misjudged the effect of rising interest rates on property prices in 2023. The fall in the housing market was much less sharp than I had anticipated. 

The reason is that lower demand (which I did foresee) was offset by a drop in supply (which I did not). As a result, the impact of increased borrowing costs was less profound than I expected.

I’ll therefore be interested in any information about how many houses Persimmon is building and how much it is selling them for. This might well offer useful data for the stocks I do own.

Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice.

Trading updates

Working out which stocks to buy, in my view, involves knowing how the business is performing. But it also involves understanding how the company fits into the wider industry.

Trading updates can be useful for both of these purposes. That’s why I’ll be paying attention when these FTSE 250 companies issue their reports this week.

Stephen Wright has positions in Forterra Plc, Primary Health Properties Plc, and Supermarket Income REIT Plc. The Motley Fool UK has recommended Primary Health Properties Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Caucasian woman with pink her studying from her laptop screen
Investing Articles

New to investing? Here’s Warren Buffett’s strategy for starting from scratch

Warren Buffett says he could find opportunities to earn a 50% annual return in the stock market if he was…

Read more »

Investing Articles

Can the sensational Barclays share price do it all over again in 2026?

Harvey Jones is blown away by what the Barclays share price has been doing lately. Now he looks at whether…

Read more »

Investing Articles

Prediction: in 2026 mega-cheap Diageo shares could turn £10,000 into…

Diageo shares have been burning wealth lately but Harvey Jones says long-suffering investors in the FTSE 100 stock may get…

Read more »

Investing Articles

This overlooked FTSE 100 share massively outperformed Tesla over 5 years!

Tesla has been a great long-term investment, but this lesser-known FTSE 100 company would have been an even better one.

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

I’m backing these 3 value stocks to the hilt – will they rocket in 2026?

Harvey Jones has bought these three FTSE 100 value stocks on three occasions lately, averaging down every time they fall.…

Read more »

Investing Articles

Can the barnstorming Tesco share price do it all over again in 2026?

Harvey Jones is blown away by just how well the Tesco share price has done lately, and asks whether the…

Read more »

Investing Articles

Up 45% in a year with a 7.2% yield and a P/E of 13! Is it too late to buy this fabulous FTSE 250 stock?

Harvey Jones spotted the potential in this ultra-high-yielding FTSE 250 recovery stock, and is thrilled to see it starting to…

Read more »

Investing Articles

What on earth’s going to happen to the BP share price in 2026?

Harvey Jones looks at how the BP share price is shaping up for the year ahead, and finds investors have…

Read more »